COPD and Osteoporosis

Links shared publicly online about this topic

Prevalence and Progression of Osteoporosis in Patients With COPD " CHEST

chestjournal.chestpubs.org — “Ferguson, Gary T.; Calverley, Peter M. A.; Anderson, Julie A.; Jenkins, Christine R.; Jones, Paul W.; Willits, Lisa R.; Yates, Julie C.; Vestbo, Jrgen; Celli, BartolomeView full resource at chestjournal.chestpubs.org

  • View Related
  • Share

Most Recently Shared on December 8, 2009 at 10:08 am By:

wheezemd Michael Blaiss, MD Physician, Doctor, and Allergist

Prevalence and Progression of Osteoporosis in Patients With COPDResults From the Towards a Revolution in COPD Health http://is.gd/5fMV5

2 years ago...

FDA approves Forest Labs' Daliresp to treat COPD

news-medical.net — “Forest Laboratories, Inc. announced today that Daliresp was approved by the U.S. Food and Drug Administration as a treatment to reduce the risk of chronic obstructive pulmonary disease exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 11:37 am By:

Osteoporosis_nt News-Medical.Net Health News

Osteoporosis News: FDA approves Forest Labs' Daliresp to treat COPD: Forest Laboratories, Inc. announced today t... http://bit.ly/gN2zHY

11 months ago...

No evidence inhaled corticosteroids increase osteoporosis risk | News | Nursing Times

nursingtimes.net — “A study has found that treatment with inhaled corticosteroids does not increase risk of osteoporosis in patients with COPDView full resource at nursingtimes.net

  • View Related
  • Share

Most Recently Shared on January 11, 2010 at 5:08 pm By:

NursingTimes Nursing Times Health Magazine

News: No evidence inhaled corticosteroids increase osteoporosis risk http://bit.ly/7JGmFY

2 years ago...

FDA issues complete response letter for roflumilast NDA

news-medical.net — “Forest Laboratories, Inc. and Nycomed today announced that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for roflumilast. Roflumilast was reviewed as a potential treatment to reduce COPD exacerbations associated with chronic bronchitis in patients at risk for exacerbations.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 18, 2010 at 7:54 am By:

Osteoporosis_nt News-Medical.Net Health News

Osteoporosis News: FDA issues complete response letter for roflumilast NDA: Forest Laboratories, Inc. and Nycomed ... http://bit.ly/bVr12Z

2 years ago...

Journal Chest: December highlighted studies

eurekalert.org — “New studies in the December issue of the journal Chest show that COPD may be linked to both osteoporosis and acid reflux, while asthma may be linked to poor mental health.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on December 4, 2008 at 5:34 am By:

eurekalert science news Health News

AAAS Journal CHEST: December highlighted studies http://tinyurl.com/698aou

3 years ago...

Vitamin D deficiency linked to asthma, COPD - Digestion, health and nutrition: Dr. Anil Minocha, a gastroenterologist and nutritionist

minochahealth.typepad.com — “Home page Facebook Dr. Minocha Vitamin D deficiency is an exploding epidemic. Besides bone disorders like osteoporosis, vitamin D has been associated a with a variety of ailments including skin disorders, infection and cancer. Multiple reports document that illnesess as...View full resource at minochahealth.typepad.com

  • View Related
  • Share

Most Recently Shared on February 4, 2010 at 12:29 am By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390